{"preliminary_commentary":{"by_channel":{"x_thread":3},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this."},"free_build":{"available":false},"commentary_summary":null,"drugs_tested":[["niraparib"]],"indication":"platinum-sensitive castration-resistant prostate cancer with DNA repair defects","name":"PLATPARP","nct_id":"NCT04288687","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=platparp-nct04288687. The price is an estimate of verified statements from the commentary indexed so far. Final coverage is set when the report is built. You never pay more than quoted: if the report is delivered at a smaller size, you pay that size's price, and anything paid above it is refunded. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_rule":"Never more than quoted: the buyer pays the smaller of price_usd and the price the delivered edition is sold at.","price_usd":750,"size":"focused","size_rule":"Focused: 1–150 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":null,"arms":[{"description":"Niraparib 200 mg by mouth daily (2 x 100 mg pills) on a 28 day cycle","label":"Niraparib Arm (only arm)","type":"OTHER"}],"collaborators":[],"completion_date":{"date":"2024-02-20","type":"ACTUAL"},"conditions":["Prostate Adenocarcinoma"],"enrollment":{"count":11,"type":"ACTUAL"},"has_results":true,"interventions":[{"name":"Niraparib Pill","otherNames":[],"type":"DRUG"}],"last_update":"2026-03-04","lead_sponsor":"Abramson Cancer Center at Penn Medicine","official_title":"PLATPARP: A Phase II Single-Arm Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects","overall_status":"COMPLETED","phases":["PHASE2"],"primary_completion_date":{"date":"2024-02-20","type":"ACTUAL"},"primary_outcomes":[{"measure":"6-Month Radiographic Progression-Free Survival (rPFS6)","timeFrame":"6 months from initiation of maintenance niraparib therapy"}],"references":[],"start_date":{"date":"2020-10-19","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects","url":"https://clinicaltrials.gov/study/NCT04288687"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.2","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/platparp-nct04288687"}